Taiwan Liposome Company, Ltd. – NASDAQ:TLC

Market open

Closed in about 6 hours

-7.04%

month

+6.54%

quarter

+59.09%

year

Market Cap	N/A
Enterprise value	N/A

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Q Y

Taiwan Liposome Company, Ltd. (NASDAQ:TLC): Earnings per share (EPS)
2021-05-14	-0.16	-0.16
2021-08-12	-0.2	-0.04

Q Y

Q Y

Status	Patent	Filling date	Issue date
Application	Application PHARMACEUTICAL COMPOSITIONS FOR USE IN TREATING PAIN Filling date: 26 Feb 2020 Issue date: 10 Mar 2022	26 Feb 2020	10 Mar 2022
Application	Application LIPOSOMAL COMPOSITION CONTAINING MILD ACIDIC ACTIVE AGENT Filling date: 4 Aug 2021 Issue date: 23 Dec 2021	4 Aug 2021	23 Dec 2021
Grant	Grant Utility: Pharmaceutical compositions of hydrophobic camptothecin derivatives Filling date: 3 Jul 2019 Issue date: 20 Apr 2021	3 Jul 2019	20 Apr 2021
Application	Application PHARMACEUTICAL COMPOSITIONS OF HYDROPHOBIC CAMPTOTHECIN DERIVATIVES Filling date: 3 Jul 2019 Issue date: 24 Oct 2019	3 Jul 2019	24 Oct 2019
Grant	Grant Utility: Pharmaceutical compositions of hydrophobic camptothecin derivatives Filling date: 2 Nov 2012 Issue date: 27 Aug 2019	2 Nov 2012	27 Aug 2019

Monday, 22 July 2024
13:00	Glad® and T-Boz Bring `90s Nostalgia to the Household Cleaning Experience	prnewswire.com
Monday, 20 May 2024
11:01	Life Science Equipment Market to be Worth $97.96 Billion by 2031 - Exclusive Report by Meticulous Research®	https://www.prnewswire.com
Tuesday, 23 April 2024
05:19	Samsung Electronics Begins Industry’s First Mass Production of 9th-Gen V-NAND	headlinesoftoday.com
05:19	Samsung Electronics Begins Industry’s First Mass Production of 9th-Gen V-NAND	headlinesoftoday.com
Monday, 20 November 2023
03:54	Highlights of Dr. David Hunter's Oral Presentation at ACR's Late Breaking Abstracts Session	globenewswire.com
Wednesday, 8 November 2023
04:54	TLC to Present Phase 3 Data of TLC599 in Late-Breaking Abstracts Session at ACR	GlobeNewsWire
Wednesday, 8 September 2021
04:41	TLC Announces Voluntary Delisting and Deregistration of American Depositary Shares	GlobeNewsWire

What's the price of Taiwan Liposome Company, Ltd. stock today?

One share of Taiwan Liposome Company, Ltd. stock can currently be purchased for approximately $7.
When is Taiwan Liposome Company, Ltd.'s next earnings date?

Unfortunately, Taiwan Liposome Company, Ltd.'s (TLC) next earnings date is currently unknown.
Does Taiwan Liposome Company, Ltd. pay dividends?

No, Taiwan Liposome Company, Ltd. does not pay dividends.
What is Taiwan Liposome Company, Ltd.'s stock symbol?

Taiwan Liposome Company, Ltd. is traded on the NASDAQ under the ticker symbol "TLC".
What is Taiwan Liposome Company, Ltd.'s primary industry?

Company operates in the Healthcare sector and Biotechnology industry.
How do i buy shares of Taiwan Liposome Company, Ltd.?

Shares of Taiwan Liposome Company, Ltd. can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
When Taiwan Liposome Company, Ltd. went public?

Taiwan Liposome Company, Ltd. is publicly traded company for more then 6 years since IPO on 21 Nov 2018.
What is Taiwan Liposome Company, Ltd.'s official website?

The official website for Taiwan Liposome Company, Ltd. is tlcbio.com.
How can i contact Taiwan Liposome Company, Ltd.?

Taiwan Liposome Company, Ltd. can be reached via phone at +886 2 2655 7377.